You just read:

Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

News provided by

Kyowa Kirin International PLC

Dec 15, 2017, 08:30 ET